ArticleAntioxidants (Basel, Switzerland)2026
Green Tea Extract Attenuates Oxidative Stress and Prolongs Red Blood Cell Survival in Iron-Overloaded β-Thalassemic Mice.
Article in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Green tea extract (GTE) contains catechin polyphenols with potent antioxidant and iron-chelating activities. This study investigated whether GTE could attenuate oxidative stress and improve red blood cell (RBC) survival in iron-overloaded β-thalassemic mice. Catechin composition and antioxidant activity of GTE and black tea extract (BTE) were evaluated using HPLC-photodiode array detection and ABTS radical scavenging assays. Anti-hemolytic effects were examined in RBC from healthy subjects and transfusion-dependent β-thalassemia patients. In vivo studies were performed using male C57BL/6J wild-type (WT) and heterozygous β-globin knockout (BKO) mice fed a ferrocene-enriched diet to induce iron overload. Mice subsequently received oral GTE (300 mg/kg/day) or deferiprone (DFP, 50 mg/kg/day) for 12 weeks. GTE contained markedly higher levels of catechin derivatives, particularly epigallocatechin-3-gallate, and exhibited stronger antioxidant activity than BTE. GTE significantly reduced RBC hemolysis, reactive oxygen species, malondialdehyde, and plasma non-transferrin-bound iron levels while restoring glutathione concentrations and prolonging RBC survival in iron-overloaded mice. The protective effects of GTE were comparable to DFP treatment. These findings suggest that GTE may serve as a promising natural adjunctive strategy for reducing oxidative injuries in β-thalassemia and iron-overload disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.